We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.06B
1-Year Est. Return
24.93%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$550M
AUM Growth
+$47.8M
(+9.5%)
Cap. Flow
-$677K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
269
New
1
Increased
2
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$991K |
| 2 |
Truist Financial
TFC
|
+$326K |
| 3 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$45K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.72M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$320K |
| 3 |
3M
MMM
|
+$560 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.68% |
| 2 | Healthcare | 14.72% |
| 3 | Financials | 13.9% |
| 4 | Communication Services | 10.73% |
| 5 | Consumer Staples | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mastercard
MA
$469B
| $2.83M | 0.52% |
9,483
| – | – |
|
52
UnitedHealth
UNH
$385B
| $2.82M | 0.51% |
9,594
| – | – |
|
53
Netflix
NFLX
$287B
| $2.82M | 0.51% |
87,020
| – | – |
|
54
Vertex Pharmaceuticals
VRTX
$120B
| $2.81M | 0.51% |
12,857
| – | – |
|
55
CBRE Group
CBRE
$39.7B
| $2.74M | 0.5% |
44,693
| – | – |
|
56
Gilead Sciences
GILD
$162B
| $2.68M | 0.49% |
41,197
| – | – |
|
57
Booking.com
BKNG
$134B
| $2.61M | 0.47% |
31,775
| – | – |
|
58
Home Depot
HD
$324B
| $2.58M | 0.47% |
11,799
| – | – |
|
59
Autodesk
ADSK
$43.3B
| $2.55M | 0.46% |
13,901
| – | – |
|
|
LPT
60
DELISTED
Liberty Property Trust
LPT
| $2.5M | 0.45% |
41,274
| – | – |
|
61
Expeditors International
EXPD
$23B
| $2.46M | 0.45% |
31,579
| – | – |
|
62
PNC Financial Services
PNC
$99.5B
| $2.41M | 0.44% |
15,114
| – | – |
|
63
Lowe's Companies
LOW
$113B
| $2.39M | 0.44% |
19,979
| – | – |
|
64
Waters Corp
WAT
$37.5B
| $2.39M | 0.44% |
10,242
| – | – |
|
65
Marriott International
MAR
$96.1B
| $2.39M | 0.43% |
15,792
| – | – |
|
66
Wells Fargo
WFC
$261B
| $2.38M | 0.43% |
44,220
| – | – |
|
67
Equinix
EQIX
$102B
| $2.38M | 0.43% |
4,071
| – | – |
|
68
Eversource Energy
ES
$28.1B
| $2.34M | 0.43% |
27,495
| – | – |
|
69
Henry Schein
HSIC
$9.63B
| $2.31M | 0.42% |
34,664
| – | – |
|
70
Tesla
TSLA
$1.2T
| $2.29M | 0.42% |
82,110
| – | – |
|
71
Pfizer
PFE
$143B
| $2.29M | 0.42% |
61,588
| – | – |
|
72
United Parcel Service
UPS
$97B
| $2.27M | 0.41% |
19,413
| – | – |
|
73
General Mills
GIS
$19B
| $2.27M | 0.41% |
42,373
| – | – |
|
74
Clorox
CLX
$11.3B
| $2.21M | 0.4% |
14,367
| – | – |
|
75
Intuit
INTU
$77B
| $2.19M | 0.4% |
8,382
| – | – |
|
Similar funds
MWA
SFP
CA
MFS
ECM
NRG
HW
LAM
Kintegral Advisory's Q4 2019 Portfolio in Review
As of Q4 2019, Kintegral Advisory held 269 positions worth $550M, up 9.5% from $502M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 1.1%. Kintegral Advisory opened 1 new position and exited 2, leaving the 269-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Kintegral Advisory's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 17,299 shares worth $52K.
- Kintegral Advisory added most to Bristol-Myers Squibb in Q4 2019, an estimated $991K increase.
- Kintegral Advisory's biggest Q4 2019 reduction was 3M, cutting an estimated $560.
- Kintegral Advisory fully exited Celgene Corp in Q4 2019, selling an estimated $1.72M.
- Kintegral Advisory's ten largest holdings make up 29% of its $550M portfolio in Q4 2019.
- Kintegral Advisory opened 1 new position and closed 2 in Q4 2019.
- Kintegral Advisory's portfolio value rose 9.5% quarter-over-quarter to $550M.
Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.